Global Covid-19 Vaccine Market Growth (Status and Outlook) 2025-2031

January 2025 | 90 pages | ID: GFB22D03827AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Covid-19 Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.

The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.

The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.

North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.

LPI (LP Information)' newest research report, the “Covid-19 Vaccine Industry Forecast” looks at past sales and reviews total world Covid-19 Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Covid-19 Vaccine sales for 2025 through 2031. With Covid-19 Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Covid-19 Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Covid-19 Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Covid-19 Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Covid-19 Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Covid-19 Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Covid-19 Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Covid-19 Vaccine market by product type, application, key players and key regions and countries.

Segmentation by Type:

• DNA
• Non-replicating Viral Vector
• Protein Subunit
• RNA
• Others

Segmentation by Application:

• Adults
• Children

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Moderna
• CanSino Biologicals
• Inovio Pharmaceuticals
• Shenzhen Geno-Immune Medical Institute
• GlaxoSmithKine
• Pfizer
• Johnson?Johnson
• Heat Biologics
• Sanofi

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Covid-19 Vaccine Market Size (2020-2031)
  2.1.2 Covid-19 Vaccine Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Covid-19 Vaccine by Country/Region (2020, 2024 & 2031)
2.2 Covid-19 Vaccine Segment by Type
  2.2.1 DNA
  2.2.2 Non-replicating Viral Vector
  2.2.3 Protein Subunit
  2.2.4 RNA
  2.2.5 Others
2.3 Covid-19 Vaccine Market Size by Type
  2.3.1 Covid-19 Vaccine Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Covid-19 Vaccine Market Size Market Share by Type (2020-2025)
2.4 Covid-19 Vaccine Segment by Application
  2.4.1 Adults
  2.4.2 Children
2.5 Covid-19 Vaccine Market Size by Application
  2.5.1 Covid-19 Vaccine Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Covid-19 Vaccine Market Size Market Share by Application (2020-2025)

3 COVID-19 VACCINE MARKET SIZE BY PLAYER

3.1 Covid-19 Vaccine Market Size Market Share by Player
  3.1.1 Global Covid-19 Vaccine Revenue by Player (2020-2025)
  3.1.2 Global Covid-19 Vaccine Revenue Market Share by Player (2020-2025)
3.2 Global Covid-19 Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 COVID-19 VACCINE BY REGION

4.1 Covid-19 Vaccine Market Size by Region (2020-2025)
4.2 Global Covid-19 Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Covid-19 Vaccine Market Size Growth (2020-2025)
4.4 APAC Covid-19 Vaccine Market Size Growth (2020-2025)
4.5 Europe Covid-19 Vaccine Market Size Growth (2020-2025)
4.6 Middle East & Africa Covid-19 Vaccine Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Covid-19 Vaccine Market Size by Country (2020-2025)
5.2 Americas Covid-19 Vaccine Market Size by Type (2020-2025)
5.3 Americas Covid-19 Vaccine Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Covid-19 Vaccine Market Size by Region (2020-2025)
6.2 APAC Covid-19 Vaccine Market Size by Type (2020-2025)
6.3 APAC Covid-19 Vaccine Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Covid-19 Vaccine Market Size by Country (2020-2025)
7.2 Europe Covid-19 Vaccine Market Size by Type (2020-2025)
7.3 Europe Covid-19 Vaccine Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Covid-19 Vaccine by Region (2020-2025)
8.2 Middle East & Africa Covid-19 Vaccine Market Size by Type (2020-2025)
8.3 Middle East & Africa Covid-19 Vaccine Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL COVID-19 VACCINE MARKET FORECAST

10.1 Global Covid-19 Vaccine Forecast by Region (2026-2031)
  10.1.1 Global Covid-19 Vaccine Forecast by Region (2026-2031)
  10.1.2 Americas Covid-19 Vaccine Forecast
  10.1.3 APAC Covid-19 Vaccine Forecast
  10.1.4 Europe Covid-19 Vaccine Forecast
  10.1.5 Middle East & Africa Covid-19 Vaccine Forecast
10.2 Americas Covid-19 Vaccine Forecast by Country (2026-2031)
  10.2.1 United States Market Covid-19 Vaccine Forecast
  10.2.2 Canada Market Covid-19 Vaccine Forecast
  10.2.3 Mexico Market Covid-19 Vaccine Forecast
  10.2.4 Brazil Market Covid-19 Vaccine Forecast
10.3 APAC Covid-19 Vaccine Forecast by Region (2026-2031)
  10.3.1 China Covid-19 Vaccine Market Forecast
  10.3.2 Japan Market Covid-19 Vaccine Forecast
  10.3.3 Korea Market Covid-19 Vaccine Forecast
  10.3.4 Southeast Asia Market Covid-19 Vaccine Forecast
  10.3.5 India Market Covid-19 Vaccine Forecast
  10.3.6 Australia Market Covid-19 Vaccine Forecast
10.4 Europe Covid-19 Vaccine Forecast by Country (2026-2031)
  10.4.1 Germany Market Covid-19 Vaccine Forecast
  10.4.2 France Market Covid-19 Vaccine Forecast
  10.4.3 UK Market Covid-19 Vaccine Forecast
  10.4.4 Italy Market Covid-19 Vaccine Forecast
  10.4.5 Russia Market Covid-19 Vaccine Forecast
10.5 Middle East & Africa Covid-19 Vaccine Forecast by Region (2026-2031)
  10.5.1 Egypt Market Covid-19 Vaccine Forecast
  10.5.2 South Africa Market Covid-19 Vaccine Forecast
  10.5.3 Israel Market Covid-19 Vaccine Forecast
  10.5.4 Turkey Market Covid-19 Vaccine Forecast
10.6 Global Covid-19 Vaccine Forecast by Type (2026-2031)
10.7 Global Covid-19 Vaccine Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Covid-19 Vaccine Forecast

11 KEY PLAYERS ANALYSIS

11.1 Moderna
  11.1.1 Moderna Company Information
  11.1.2 Moderna Covid-19 Vaccine Product Offered
  11.1.3 Moderna Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Moderna Main Business Overview
  11.1.5 Moderna Latest Developments
11.2 CanSino Biologicals
  11.2.1 CanSino Biologicals Company Information
  11.2.2 CanSino Biologicals Covid-19 Vaccine Product Offered
  11.2.3 CanSino Biologicals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 CanSino Biologicals Main Business Overview
  11.2.5 CanSino Biologicals Latest Developments
11.3 Inovio Pharmaceuticals
  11.3.1 Inovio Pharmaceuticals Company Information
  11.3.2 Inovio Pharmaceuticals Covid-19 Vaccine Product Offered
  11.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Inovio Pharmaceuticals Main Business Overview
  11.3.5 Inovio Pharmaceuticals Latest Developments
11.4 Shenzhen Geno-Immune Medical Institute
  11.4.1 Shenzhen Geno-Immune Medical Institute Company Information
  11.4.2 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product Offered
  11.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Shenzhen Geno-Immune Medical Institute Main Business Overview
  11.4.5 Shenzhen Geno-Immune Medical Institute Latest Developments
11.5 GlaxoSmithKine
  11.5.1 GlaxoSmithKine Company Information
  11.5.2 GlaxoSmithKine Covid-19 Vaccine Product Offered
  11.5.3 GlaxoSmithKine Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 GlaxoSmithKine Main Business Overview
  11.5.5 GlaxoSmithKine Latest Developments
11.6 Pfizer
  11.6.1 Pfizer Company Information
  11.6.2 Pfizer Covid-19 Vaccine Product Offered
  11.6.3 Pfizer Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Pfizer Main Business Overview
  11.6.5 Pfizer Latest Developments
11.7 Johnson?Johnson
  11.7.1 Johnson?Johnson Company Information
  11.7.2 Johnson?Johnson Covid-19 Vaccine Product Offered
  11.7.3 Johnson?Johnson Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Johnson?Johnson Main Business Overview
  11.7.5 Johnson?Johnson Latest Developments
11.8 Heat Biologics
  11.8.1 Heat Biologics Company Information
  11.8.2 Heat Biologics Covid-19 Vaccine Product Offered
  11.8.3 Heat Biologics Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Heat Biologics Main Business Overview
  11.8.5 Heat Biologics Latest Developments
11.9 Sanofi
  11.9.1 Sanofi Company Information
  11.9.2 Sanofi Covid-19 Vaccine Product Offered
  11.9.3 Sanofi Covid-19 Vaccine Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Sanofi Main Business Overview
  11.9.5 Sanofi Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1. Covid-19 Vaccine Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Covid-19 Vaccine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of DNA
Table 4. Major Players of Non-replicating Viral Vector
Table 5. Major Players of Protein Subunit
Table 6. Major Players of RNA
Table 7. Major Players of Others
Table 8. Covid-19 Vaccine Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Covid-19 Vaccine Market Size byType (2020-2025) & ($ millions)
Table 10. Global Covid-19 Vaccine Market Size Market Share byType (2020-2025)
Table 11. Covid-19 Vaccine Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Covid-19 Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Covid-19 Vaccine Market Size Market Share by Application (2020-2025)
Table 14. Global Covid-19 Vaccine Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Covid-19 Vaccine Revenue Market Share by Player (2020-2025)
Table 16. Covid-19 Vaccine Key Players Head office and Products Offered
Table 17. Covid-19 Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Covid-19 Vaccine Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Covid-19 Vaccine Market Size Market Share by Region (2020-2025)
Table 22. Global Covid-19 Vaccine Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Covid-19 Vaccine Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Covid-19 Vaccine Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Covid-19 Vaccine Market Size Market Share by Country (2020-2025)
Table 26. Americas Covid-19 Vaccine Market Size byType (2020-2025) & ($ millions)
Table 27. Americas Covid-19 Vaccine Market Size Market Share byType (2020-2025)
Table 28. Americas Covid-19 Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Covid-19 Vaccine Market Size Market Share by Application (2020-2025)
Table 30. APAC Covid-19 Vaccine Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Covid-19 Vaccine Market Size Market Share by Region (2020-2025)
Table 32. APAC Covid-19 Vaccine Market Size byType (2020-2025) & ($ millions)
Table 33. APAC Covid-19 Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Covid-19 Vaccine Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Covid-19 Vaccine Market Size Market Share by Country (2020-2025)
Table 36. Europe Covid-19 Vaccine Market Size byType (2020-2025) & ($ millions)
Table 37. Europe Covid-19 Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Covid-19 Vaccine Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Covid-19 Vaccine Market Size byType (2020-2025) & ($ millions)
Table 40. Middle East & Africa Covid-19 Vaccine Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Covid-19 Vaccine
Table 42. Key Market Challenges & Risks of Covid-19 Vaccine
Table 43. Key IndustryTrends of Covid-19 Vaccine
Table 44. Global Covid-19 Vaccine Market SizeForecast by Region (2026-2031) & ($ millions)
Table 45. Global Covid-19 Vaccine Market Size Market ShareForecast by Region (2026-2031)
Table 46. Global Covid-19 Vaccine Market SizeForecast byType (2026-2031) & ($ millions)
Table 47. Global Covid-19 Vaccine Market SizeForecast by Application (2026-2031) & ($ millions)
Table 48. Moderna Details, CompanyType, Covid-19 Vaccine Area Served and Its Competitors
Table 49. Moderna Covid-19 Vaccine Product Offered
Table 50. Moderna Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Moderna Main Business
Table 52. Moderna Latest Developments
Table 53. CanSino Biologicals Details, CompanyType, Covid-19 Vaccine Area Served and Its Competitors
Table 54. CanSino Biologicals Covid-19 Vaccine Product Offered
Table 55. CanSino Biologicals Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. CanSino Biologicals Main Business
Table 57. CanSino Biologicals Latest Developments
Table 58. Inovio Pharmaceuticals Details, CompanyType, Covid-19 Vaccine Area Served and Its Competitors
Table 59. Inovio Pharmaceuticals Covid-19 Vaccine Product Offered
Table 60. Inovio Pharmaceuticals Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Inovio Pharmaceuticals Main Business
Table 62. Inovio Pharmaceuticals Latest Developments
Table 63. Shenzhen Geno-Immune Medical Institute Details, CompanyType, Covid-19 Vaccine Area Served and Its Competitors
Table 64. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product Offered
Table 65. Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Shenzhen Geno-Immune Medical Institute Main Business
Table 67. Shenzhen Geno-Immune Medical Institute Latest Developments
Table 68. GlaxoSmithKine Details, CompanyType, Covid-19 Vaccine Area Served and Its Competitors
Table 69. GlaxoSmithKine Covid-19 Vaccine Product Offered
Table 70. GlaxoSmithKine Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. GlaxoSmithKine Main Business
Table 72. GlaxoSmithKine Latest Developments
Table 73. Pfizer Details, CompanyType, Covid-19 Vaccine Area Served and Its Competitors
Table 74. Pfizer Covid-19 Vaccine Product Offered
Table 75. Pfizer Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Pfizer Main Business
Table 77. Pfizer Latest Developments
Table 78. Johnson?Johnson Details, CompanyType, Covid-19 Vaccine Area Served and Its Competitors
Table 79. Johnson?Johnson Covid-19 Vaccine Product Offered
Table 80. Johnson?Johnson Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Johnson?Johnson Main Business
Table 82. Johnson?Johnson Latest Developments
Table 83. Heat Biologics Details, CompanyType, Covid-19 Vaccine Area Served and Its Competitors
Table 84. Heat Biologics Covid-19 Vaccine Product Offered
Table 85. Heat Biologics Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Heat Biologics Main Business
Table 87. Heat Biologics Latest Developments
Table 88. Sanofi Details, CompanyType, Covid-19 Vaccine Area Served and Its Competitors
Table 89. Sanofi Covid-19 Vaccine Product Offered
Table 90. Sanofi Covid-19 Vaccine Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Sanofi Main Business
Table 92. Sanofi Latest Developments



LIST OFFIGURES

Figure 1. Covid-19 Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Covid-19 Vaccine Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Covid-19 Vaccine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Covid-19 Vaccine Sales Market Share by Country/Region (2024)
Figure 8. Covid-19 Vaccine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Covid-19 Vaccine Market Size Market Share byType in 2024
Figure 10. Covid-19 Vaccine in Adults
Figure 11. Global Covid-19 Vaccine Market: Adults (2020-2025) & ($ millions)
Figure 12. Covid-19 Vaccine in Children
Figure 13. Global Covid-19 Vaccine Market: Children (2020-2025) & ($ millions)
Figure 14. Global Covid-19 Vaccine Market Size Market Share by Application in 2024
Figure 15. Global Covid-19 Vaccine Revenue Market Share by Player in 2024
Figure 16. Global Covid-19 Vaccine Market Size Market Share by Region (2020-2025)
Figure 17. Americas Covid-19 Vaccine Market Size 2020-2025 ($ millions)
Figure 18. APAC Covid-19 Vaccine Market Size 2020-2025 ($ millions)
Figure 19. Europe Covid-19 Vaccine Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Covid-19 Vaccine Market Size 2020-2025 ($ millions)
Figure 21. Americas Covid-19 Vaccine Value Market Share by Country in 2024
Figure 22. United States Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Covid-19 Vaccine Market Size Market Share by Region in 2024
Figure 27. APAC Covid-19 Vaccine Market Size Market Share byType (2020-2025)
Figure 28. APAC Covid-19 Vaccine Market Size Market Share by Application (2020-2025)
Figure 29. China Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 33. India Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Covid-19 Vaccine Market Size Market Share by Country in 2024
Figure 36. Europe Covid-19 Vaccine Market Size Market Share byType (2020-2025)
Figure 37. Europe Covid-19 Vaccine Market Size Market Share by Application (2020-2025)
Figure 38. Germany Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 39.France Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Covid-19 Vaccine Market Size Market Share byType (2020-2025)
Figure 45. Middle East & Africa Covid-19 Vaccine Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 49.Turkey Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Covid-19 Vaccine Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 52. APAC Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 53. Europe Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 55. United States Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 56. Canada Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 57. Mexico Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 58. Brazil Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 59. China Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 60. Japan Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 61. Korea Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 63. India Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 64. Australia Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 65. Germany Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 66.France Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 67. UK Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 68. Italy Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 69. Russia Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 70. Egypt Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 71. South Africa Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 72. Israel Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 73.Turkey Covid-19 Vaccine Market Size 2026-2031 ($ millions)
Figure 74. Global Covid-19 Vaccine Market Size Market ShareForecast byType (2026-2031)
Figure 75. Global Covid-19 Vaccine Market Size Market ShareForecast by Application (2026-2031)
Figure 76. GCC Countries Covid-19 Vaccine Market Size 2026-2031 ($ millions)